FDA product code · Clinical Chemistry · Class 2

LCX: Kit, Test, Pregnancy, Hcg, Over The Counter

LCX is FDA's product code for "Kit, Test, Pregnancy, Hcg, Over The Counter": a Class 2 device classified under 21 CFR 862.1155, reviewed by the Clinical Chemistry panel.

510(k) review time for LCX

Across 38 510(k) clearances under LCX decided from 2018-01-01 to 2026-10-06, the median was 155 days from FDA receipt to decision. Half took between 59 and 245 days, and 80% were decided within 259 days. These are past clearances, not a forecast for a new submission.

Days from FDA receipt to 510(k) decision, LCX, decisions 2018-01-01 to 2026-10-06 (n = 38)
Fastest27
25th percentile59
Median155
75th percentile245
80th percentile259
90th percentile290
Slowest494
Median days by decision year, LCX (years with enough clearances to compute). The partial final year counts only submissions already decided, so its median runs low.
YearMedian daysn
2019507
20222646
202413210
20251025

Source: openFDA 510(k) records, snapshot of 2026-10-06 (openFDA data as of 2026-09-28). Compare 510(k) review times across all device types, see every code side by side in the Clearance Timeline Estimator, or browse the clearances themselves in PredicateScope.

LCX in the public FDA record

Records naming LCX, from openFDA (snapshot of 2026-09-15)
510(k) clearances, all years226
Device recalls25
Establishment listings272
GUDID device identifiers880

Counts of records, not of devices or events. Adverse event reports for LCX are in MAUDEScope, as counts with the query shown: MAUDE has no denominator, so a report count is not a rate and does not show that a device caused an event.

FDA-recognized standards that cite LCX

No FDA recognized consensus standard cites LCX by product code. Horizontal standards such as biocompatibility, sterilization and software standards can still apply.

Source: FDA Recognized Consensus Standards, snapshot of 2026-09-01. Search them all in the Consensus Standards Lookup.

Related product codes